NAME CTS AFFILIATION DISCLOSURE UPDATED

Similar documents
ADVANCING KNOWLEDGE. IMPROVING OUTCOMES ANNUAL REPORT

JABLONSKI DEBATES PSA TESTING

E xe c ut ive Summar y Prevention of Acute Exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

Podcast/MP3 Instructions 1. Download the Podcast or MP3 audio file to your player. 2. Listen to the presentation. 3. To receive continuing education

Beyond the Next Breath: Controlling Costs and Maximizing COPD Outcomes

Podcast/MP3 Instructions 1. Download the Podcast or MP3 audio file to your player. 2. Listen to the presentation. 3. To receive continuing education

Saskatchewan Thoracic Society NEWS The Respiratory Health Care Professional Section of the Lung Association September 2003

Michelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier

The Physicians Practice Assessment Questionnaire on asthma and COPD

Canadian Stroke Best Practice Recommendations STROKE PREVENTION WRITING GROUP 2017:

NATIONAL PREVENTION STRATEGY MEETING:

SUMMARY OF CURRICULUM VITAE LUIS SOUHAMI, MD

PLATINUM SILVER BRONZE

Cardiopulmonary Exercise Testing Cases

Implementing Rapid Response Teams (RRT) National Call September 13, 2007

Industry Relationships and Institutional Affiliations

Nancy Roberts received her Bachelor of Science in

Appendix K Declarations of Interests

ENDOCRINOLOGY FOR PRIMARY CARE

Supported by an unrestricted educational grant by Merck & Co.

DERMATOLOGY PROFILE GENERAL INFORMATION

2016 ADHD Conference Speaker Biographies

Men s Health Ted Jablonski MD CCFP FCFP. ASA Banff March Associate, Crowfoot Village Family Practice, Calgary AB

OTOLARYNGOLOGY PROFILE

Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis (UNVEIL Phase IV Study)

GERIATRIC MEDICINE PROFILE

Geriatric Medicine. Geriatric Medicine Profile

A Clinical Context Report

ENDOCRINOLOGY/METABOLISM PROFILE

Professional Overview: Postdoctoral Students, Graduate Students: Vince Tedjasaputra, Heather Edgell, Linn Moore, Jon Elliot

SickKids Research Institute: List of Funders

Do the Right Thing: Good Clinical Practice for Clinical Research

Medical Aid in Dying A Year of Change

Report from the National Diabetes Surveillance System:

Critical Care Medicine. Critical Care Medicine Profile

Improving access to oral health care for vulnerable people living in Canada. A Canadian Academy of Health Sciences Report

Do Clinical Practice Guidelines Improve Outcomes?

POST-M.D. TRAINEES EXITING ALBERTA TRAINING PROGRAMS IN JULY, 2015 AT THE COMPLETION OF POST-M.D

Avoiding diagnostic error by understanding how physicians think. Patrick Croskerry PLENARY SESSION 9:00 10:00 SPEAKER PROFILE

Breathlessness research

Giancarlo Comi, M.D. On Behalf of the MS-LAQ-301 (ALLEGRO) Study Group. Assessment of oral laquinimod in preventing progression of Multiple Sclerosis

95% of care homes show clear care improvements1. Elevating Awareness & Creating Discussions Key 2016 Advocacy and Industry Efforts

Physical Medicine & Rehabilitation. Physical Medicine and Rehabilitation Profile

Technology to support a Community of Practice Promoting Healthy Built Environment Policies

Geographic Location, Field of Post-M.D. Training

MINIMALLY INVASIVE SURGERY

STEMI Care 2014 at the Crossroads: Taking the right road

CAG Quality Program in Endoscopy (QP-E: Colonoscopy) Point-of-Care Practice Audit

Physiotherapists in Canada, 2011 National and Jurisdictional Highlights

CAHS report on access to oral health care: strategic pressure for change. A Presentation for Public Health Ontario August 2015

Promius Pharma, a subsidiary of Dr. Reddy s Laboratories, Princeton, NJ; 2 Vedanta Research, Chapel Hill, NC; 3

Academic Critical Care Medicine. University of Alberta

Health Canada Endorsed Important Safety Information on Infanrix Hexa

Annual Report The Elks and Royal Purple Saskatchewan Pediatric Auditory Rehabilitation Centre

Achievements

APPROACH WORKING REPORT

Neurology. Neurology Profile

Tester s Newsletter. Published by the Lung Association of Saskatchewan Fall Spotlight on Lung Disease. COPD Exacerbation: The Lung Attack

PROVINCIAL LEAD AND LHIN LEADER BIOS

BRIEF CURRICULUM VITAE

OxyContin in the 90 days prior to it being discontinued.

# Claims with disp.fee > 0. Average cost submitted by Rx**

W H A T N A C D O E S

TABLE D-1 POST-M.D. TRAINEES EXITING QUEBEC TRAINING PROGRAMS IN JULY, 2014 AT THE COMPLETION OF POST-M.D. TRAINING

West Virginia University School of Medicine, Morgantown, West Virginia

Patient-Centred Research Priorities Relating to Healthcare of Frail Older Canadians

ORTHOPEDIC SURGERY PROFILE

Geographic Location, Field of Post-M.D. Training

Psychiatry A Recent Profile of the Profession

ESMO Symposium on Immuno-Oncology Programme book

Bruce Strober 1, 2, Chitra Karki 3, Marc Mason 3, Ning Guo 3, Jeffrey D Greenberg 3,4, Mark Lebwohl 5

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn

Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer

NATIONAL PALLIATIVE MEDICINE SURVEY QUESTIONNAIRE

CADTH Therapeutic Review Panel

Ways to talk about Diabetes Meds Tom Ransom Div. Endocrinology, Capital Health April 5, 2018

Advance Care Planning

Preschool Asthma What you need to know in 10 minutes

Targeted Therapies in the Management of Non-Small Cell Lung Cancer. A Multi-Disciplinary Approach

Stahl s Illustrated. Antidepressants. Stephen M. Stahl. University of California at San Diego. Nancy Muntner. Illustrations. Angela Felker.

SUPPLEMENTARY DATA. Telediab Study Group :

REGISTER OF INTERESTS SIGN guideline 154: Pharmacological management of glycaemic control in people with type 2 diabetes Published: 29 November 2017

Shelly A McNeil, MD on behalf of the SOS Network of the Canadian Immunization Research Network (CIRN) CIC 2016 Dec 6-8, 2016 Ottawa, ON

Primary Care Pathways

Quarter Performance Report

Financial/Commercial Relationships & Conflicts of Interest DISCLOSURES

Best of WCLC- San Francisco

LIST OF FIGURES INTRODUCTION

Economic Burden of Musculoskeletal Diseases in Canada

UBC Critical Care Medicine

Canadian Congenital Heart Alliance 2011 Annual Report

Meningococcal Education Program for Quebec Physicians: How Results Have Changed 2 Years after the Initial Program

Stroke and Headache Headache and Stroke

Bulletin of the Canadian Academy of Geriatric Psychiatry Volume 8 Number 3, Contents. President s Report... 3 DAVID K. CONN

AFATINIB FOLLOWED BY OSIMERTINIB IN REAL-WORLD PATIENTS WITH EGFR MUTATION-POSITIVE NSCLC: AN OBSERVATIONAL STUDY

(Poster presented on Sunday 05 March, 08:50 08:55; 2017 AAD Meeting, Orlando, Florida, USA)

For over 100 years, the Canadian Lung Association

Canadian Academic Detailing Collaboration

Understanding the U.S. Preventive Services Task Force and its Conflicts of Interest Policies

Provincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association

Transcription:

NAME CTS AFFILIATION DISCLOSURE UPDATED Darcy Marciniuk (Chair) and Canadian and Canadian COPD Alliance Consultant Fee, Speaker s Bureau, Advisory Committee: AstraZeneca, Boehringer-Ingelheim, Canadian Agency for Drugs and Technologies in Health, GlaxoSmithKline, Health Canada, Health Quality Council of Saskatchewan, Novartis, Nycomed, Pfizer, Prince Albert Grand Council Chronic Disease Network, Public Health Agency of Canada, Saskatoon Health Region Fiduciary Position (other than CTS or CRHP): American College of Chest Physicians, Chest Foundation, Lung Association of Saskatchewan Research/Program Grant Funding: AstraZeneca, Boehringer- Ingelheim, Canadian Institutes of Health Research, GlaxoSmithKline, Lung Association of Saskatchewan, Novartis, Pfizer, Public Health Agency of Canada, Royal University Hospital Foundation, Saskatchewan Health Research Foundation, Saskatchewan Ministry of Health, Schering-Plough March 14 th, Shawn Aaron May 13 th, 2010 Advisory Board: AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline Consultant: Health Canada Therapeutic Products Directorate, Ontario Ministry of Health and Long Term Care Pat Bailey Over the last two years, I have NOT had any affiliations (financial or otherwise) with a commercial or other organization that could lead to a real or perceived Jan 7 th, Meyer Balter and Canadian Advisory Board: AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Novartis, Nycomed, Pfizer Speaker: AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck Frosst, Nycomed, Pfizer May 4 th, 2010

Donna Bleakney External Reviewer Over the last two years, I have not had any affiliation (financial or otherwise) Dina Brooks and Canadian COPD Alliance and CRC Planning Committee Over the last two years, I have not had any affiliation (financial or otherwise) conflict of interest Scott Butcher Over the last two years, I have not had any affiliation (financial or otherwise) Richard Debigare Over the last two years, I have not had any affiliation (financial or otherwise) Gail Dechman Research/Program Grant Funding: Dalhousie University, Lung Association of Nova Scotia, Nova Scotia Health Research Foundation, Social Sciences and Humanities Research Council Membership (other than CTS or CRHP): ATS, AACVPR, Canadian Physiotherapy Association, Nova Scotia College of Physiotherapy, Nova Scotia Physiotherapy Association May 12 th, 2010 May 12 th, 2010 Gordon Ford Advisory Board and Honoraria: Abbott, Astra Zeneca, Boehringer- Ingelheim, GlaxoSmithKline, Nycomed, Pfizer, Janssen-Ortho Inc. Appointment: Medical staff, Alberta Health Services Research/Program Grant Funding: Astra Zeneca, Boehringer- Ingelheim, GlaxoSmithKline, Nycomed, Pfizer July 21 st, 2010 Donna Goodridge Appointment: University of Saskatchewan, Associate Professor, College of Nursing Speaker: Lilly (sponsored her to attend educational session on depression in COPD for primary care physicians, Sept. 2009) 1

Paul Hernandez and Canadian and Pulmonary Vascular Disease Committee and Canadian COPD Alliance Advisory Board and Consultant: AstraZeneca, Actelion, Boehringer- Ingelheim, GlaxoSmithKline, Lilly, Merck Frosst, Novartis, Nycomed, Pfizer CME Development and Speaker: AstraZeneca, Actelion, Boehringer- Ingelheim, GlaxoSmithKline, Pfizer, Canadian Conference, Atlantic Respirology and Critical Care Conference Medical Advisory Board: Lung Association of Nova Scotia, Canadian COPD Alliance Research/Program Grant Funding: AstraZeneca, Actelion, Boehringer- Ingelheim, CSL Behring, GlaxoSmithKline, Lilly, Novartis, Nycomed, Pfizer, Lung Association of Nova Scotia, Canadian Institute of Health Research, Capital Health Research Foundation Reviewer and Consultant: Canadian Agency for Drugs and Technologies in Health Vicki Kennedy Over the last two years, I have not had any affiliation (financial or otherwise) Julie Lauzon (A1AT) Appointment: Clinical staff, University of Calgary Dec 7 th, Francois Maltais Advisory Board: Boehringer-Ingelheim, GlaxoSmithKline Research/Program Grant Funding: Altana Pharma, Astra Zeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck Frosst, Novartis, Nycomed Research Chair in COPD: Canadian Institutes of Health Research and GlaxoSmithKline Speaker: Boehringer-Ingelheim, GlaxoSmithKline, Pfizer

Denis O Donnell and past President of the Canadian Thoracic Society Advisory Board: Boehringer-Ingleheim, Pfizer Canada Consulting Fees and Speaker Bureau/Honoraria: Boehringer- Ingelheim, GlaxoSmithKline, Pfizer Canada Research/Program Grant Funding: Boehringer-Ingelheim, GlaxoSmithKline, Novartis, Pfizer. Veronique Pepin May 2 nd, 2010 Advisory Board and Speaker: GlaxoSmithKline Research/Program Grant Funding: GlaxoSmithKline, Canadian Institutes of Health Research, Canadian Lung Association, Fonds de la recherche en santé du Québec, Reviewer: Fonds de la recherche en santé du Québec Darlene Reid Over the last two years, I have not had any affiliation (financial or otherwise) Graeme Rocker May 3 rd, 2010 Advisory Board: Canadian Institutes of Health Research (Panel Scientific Officer) Speaker: GlaxoSmithKline, various Universities, Pfizer (Canada, USA, UK) Research/Program Grant Funding: Canadian Institutes of Health Research, Capital Health, CHEST foundation, Lung Association of Nova Scotia, GlaxoSmithKline, Medical Research Fund New Brunswick, Atlantic Health Sciences Corporation Reviewer or Consultant: CIHR, CMAJ, CHEST, Progress in Palliative Care, J Palliat Care, J Pain Sympt Manage, Annals Intern Med, Guest Editor, J Palliat Care and Progress in Palliat Care

William Sheel Over the last two years, I have not had any affiliation (financial or otherwise) Michael Stickland May 4 th, 2010 May 9 th, 2010 Appointment: Co-director of the Centre for Lung Health, Covenant Health, Edmonton, Alberta Research/Program Grant Funding: GlaxoSmithKline, Heart and Stroke Foundation of Canada, Canadian Institutes for Health Research, Alberta Lung Association Speaker: GlaxoSmithKline David Todd Research/Program Grant Funding: AstraZeneca, Ontario Thoracic Society Shannon Walker and Membership April 28 th, 2010 Advisory Board: AstraZeneca, GlaxoSmithKline, Nycomed Appointments: On-call services, Flame Oxygen, ICU Director, Cardiopulmonary Wellness Center at InterHealth (BC),UBC teacher for residents and medical students Consultant: Boehringer-Ingelheim Speaker: AstraZeneca, BC College of Family Physicians, BC College of Therapists, Boehringer-Ingelheim, GlaxoSmithKline, Nycomed, Pfizer